| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/16/2005 | CN1582151A Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia |
| 02/16/2005 | CN1579547A Compound clostridiopeptidase compound emulsion and preparation method |
| 02/16/2005 | CN1579539A Thymic hormone beta 15 to promote wound healing and generation of blood |
| 02/16/2005 | CN1579527A Medicine for treating skin wound and its processing method |
| 02/16/2005 | CN1579525A Badger fat hair-growth promoting ointment |
| 02/16/2005 | CN1579524A Danduqing granular and its preparation method |
| 02/16/2005 | CN1579517A Quick-acting medicated liquor for treating traumatic injury |
| 02/16/2005 | CN1579512A Medicinal preparation for treating burn and scald and preparation method thereof |
| 02/16/2005 | CN1579497A Traditional Chinese medicinal preparation for treating iternal-external ulcer and its preparation method |
| 02/16/2005 | CN1579496A Ready made traditional Chinese medicine special treating extensive burn |
| 02/16/2005 | CN1579492A Resina draconis and its total flavone solution preparation and its preparation method |
| 02/16/2005 | CN1579479A Medicine for tissue-regeneration skin-grafting and preparation method thereof |
| 02/16/2005 | CN1579456A Extract of shilianhua and its function of beauty and redicals scavenging agent |
| 02/16/2005 | CN1579449A Health-care skin-care food |
| 02/16/2005 | CN1579437A Kexuanye-a medicineal liquor for treating psoriasis and its preparation method |
| 02/16/2005 | CN1579431A Cool cream |
| 02/16/2005 | CN1579428A External ready-made preparation of traditional Chinese medicine to prevent lipsotrichia and promote hair growth |
| 02/16/2005 | CN1579422A Fetus toxic liquid and its use for preparing baby's skin external products |
| 02/16/2005 | CN1579418A Preparation pixuanjing for treating psoriasis and its preparation method |
| 02/16/2005 | CN1579414A Glossy-ganoderma-spore polysaccharide for injection and its preparation process |
| 02/16/2005 | CN1579405A External medicine for killing and inhibiting fungus |
| 02/16/2005 | CN1579393A Transparaent and disappearing external medicine preparation containing benzotolazo |
| 02/16/2005 | CN1579373A Transparent disappearing external administration carrier |
| 02/16/2005 | CN1579372A Essence-oil soft capsule and its preparation method |
| 02/16/2005 | CN1579371A Fructus-amomi wind-repellent soft capsule and preparation method |
| 02/16/2005 | CN1579368A Long-service-life chinese medicine preparation for bodily diminishing inflammation and pain-relieving |
| 02/16/2005 | CN1189484C Recombined human CD11a monclone antibody and its preparation and medicinal composition |
| 02/16/2005 | CN1189482C Novel angiogenesis inhibitor |
| 02/16/2005 | CN1189479C Use of leptin in inhibition of endothelial cell proliferation |
| 02/16/2005 | CN1189214C Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 02/16/2005 | CN1189206C Medicine for curing leuconychia and hand-foot ringworm and preoaring method thereof |
| 02/16/2005 | CN1189205C Acne-eliminating moutain flower tea |
| 02/16/2005 | CN1189200C Ointment for treating burn and scald |
| 02/16/2005 | CN1189193C Ointment for treating burn |
| 02/16/2005 | CN1189188C Leukoderma curing plaster |
| 02/16/2005 | CN1189187C Medicine for curing burn |
| 02/16/2005 | CN1189186C Antiphlogistic and analgesic ointment for treating rheumatism and trauma |
| 02/16/2005 | CN1189150C Face mask for eliminating macula and whitening skin |
| 02/15/2005 | US6855860 Nonocclusive dressing comprising natural polymer fibers and a synthetic polymer foam layer having a pore-containing surface physically interlocked with the fibers; separation; nonadhesive; easy to manufacture; nontoxic; permeability |
| 02/15/2005 | US6855830 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | US6855687 Administering to the site in need of cartilage repair a polypeptide having the sequence Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Cys-Glu-Gl y-Asp-Ser-Pro-Phe-Val |
| 02/15/2005 | US6855684 Compound B as angiogenic agent in combination with human growth factors |
| 02/15/2005 | US6855528 Administering a covalently reactive antigen analog (CRAA) having an an epitope recognized irreversibly bound by catalytic antibody; autoimmune disease; a lymphoproliferative disorder; anticarcinogenic, -tumor, -inflammatory agents |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855352 Pressing and/or extraction, fruit polyphenol rich in condensed tannins (procyanidins), chlorogenic acid, and epicatechin, antibacterial antioxidative, anticancerous, antiallergic, deodoring, antiviral and blood cholesterol oxidation |
| 02/15/2005 | US6855350 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 02/15/2005 | US6855342 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 02/15/2005 | US6855325 Preventing and limiting release of chemical mediators responsible for initiating cutaneous inflammation; cosmetics |
| 02/12/2005 | CA2477357A1 Sprayable skin protectant compositions |
| 02/10/2005 | WO2005012268A1 Sulfonamide derivative having isoxazole ring |
| 02/10/2005 | WO2005011725A2 Anti-angiogenetic agent and its use, in particular in cancer treatment |
| 02/10/2005 | WO2005011717A1 Use of betulinic acid or an assayed plant extract in betulinic acid individually or associated for cosmetic, neutraceutical, veterinary and pharmaceutical use |
| 02/10/2005 | WO2005011716A1 Prebiotically active plant extracts |
| 02/10/2005 | WO2005011706A1 2-METHYLENE-19-NOR-20(S)-25-METHYL-1α-HYDROXYCALCIFEROL AND ITS USES |
| 02/10/2005 | WO2005011676A1 Composition for the treatment of vitiligo |
| 02/10/2005 | WO2005011668A1 Methods of therapeutic treatment using amounts of retinoid components |
| 02/10/2005 | WO2005011667A1 Methods of therapeutic treatment using amounts of retinoid components |
| 02/10/2005 | WO2005011663A1 Use of a biguanide derivative for protecting skin against uvb radiation |
| 02/10/2005 | WO2005011565A2 Antimycosic nail varnish |
| 02/10/2005 | WO2004098543A3 Use of oligogalacturonide-type oligosaccharides in cosmetic, food or dermatological compositions in order to stimulate epidermal cell differentiation |
| 02/10/2005 | US20050033066 Pkb-3564 substance with neovascularization inhibitory activity |
| 02/10/2005 | US20050033055 Edg receptor agonists |
| 02/10/2005 | US20050032929 Maleic anhydride-methyl vinyl ether copolymers; polyamic acids; medical implant device, dressing, scaffold, or fluid adhesive for treatment or prophylaxis of wounds; enhanced activity of protease inhibitors and neurotransmitter drugs |
| 02/10/2005 | US20050032895 Medicament for the treatment of viral skin and tumour diseases |
| 02/10/2005 | US20050032890 Aniline-derived ligands for the thyroid receptor |
| 02/10/2005 | US20050032888 Cosmetic or dermatological use to fight age-caused degeneration of the microcapillary systems of the epidermis |
| 02/10/2005 | US20050032877 Method and composition for treating burned skin |
| 02/10/2005 | US20050032874 Indole derivatives |
| 02/10/2005 | US20050032865 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 02/10/2005 | US20050032858 Novel heterocyclic compound and anti-inflamatory agent |
| 02/10/2005 | US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base |
| 02/10/2005 | US20050032830 Ether substituted imidazopyridines |
| 02/10/2005 | US20050032825 rapamaycin derivatives used as fungicides, anticarcinogenic agents, immunosuppressants or as coatings on drug eluting stents to prevent restenosis |
| 02/10/2005 | US20050032823 analgesics; antipyretics; antiinflammatory agents; antiarthritic agents |
| 02/10/2005 | US20050032816 N-oxide anthranylamide derivatives and their use as medicaments |
| 02/10/2005 | US20050032807 Treatment of cellular tumor growth, tumor proliferation or metastasis using ammonium salts of N delta -acyl derivatives of N alpha (4-amino-4-deoxypteroyl)-L-ornithine compounds |
| 02/10/2005 | US20050032786 1, 3-benzothiazinone derivatives and use thereof |
| 02/10/2005 | US20050032779 enzyme inhibitors such as 2-[4-(4-Dimethylaminophenyl)piperazin-1-yl]4,5-dihydroimidazo[4,5,1-ij]quinolin-6-one, used for treating or preventing disorders in which poly/ADP-ribose/ polymerase is involved |
| 02/10/2005 | US20050032746 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 02/10/2005 | US20050032736 Immunostimulatory nucleic acid molecules |
| 02/10/2005 | US20050032723 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/10/2005 | US20050032715 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 02/10/2005 | US20050032704 Neural thread proteins (NTP); antiproliferative agents |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032688 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 02/10/2005 | US20050032686 administering to a manimal a therapeutically effective amount of ES-62 ( a glycoprotein) to treat an inflammatory disease: arthritis and chronic obstructive pulmonary disease |
| 02/10/2005 | US20050031709 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 02/10/2005 | US20050031654 Composition based on diosgenin ester for topical use |
| 02/10/2005 | US20050031603 Obtainable from whey fraction of milk curd; centrifugation; ultrafiltration; lyophilization |
| 02/10/2005 | US20050031583 Uses of opg to modulate immune responses |
| 02/10/2005 | US20050031577 Therapeutic polyesters and polyamides |
| 02/10/2005 | US20050031572 Plant extracts for treating skin inflammation or skin degenerative conditions, caused by air pollution, nitrogen oxides in air; provide photostability, reduce side effect |
| 02/10/2005 | US20050031571 Topical treatment of ingrown hairs |
| 02/10/2005 | US20050031569 Mixture of fruit acid ester, surfactants, fatty alcohol and water for treating human skin or hair; as lipid layer enhancers, prevent skin dry out, leave pleasant feeling |
| 02/10/2005 | US20050031556 Cosmetic or dermatological light-protective formulation comprising a hydroxybenzophenone and a benzoxazole derivative |
| 02/10/2005 | US20050031555 Topically applying a stable mixture of indomethacin and moisturizing lotion to skin; storage stability |
| 02/10/2005 | US20050029705 Extrusion die |
| 02/10/2005 | DE202004018579U1 Ointment or cream composition for treating skin diseases, especially neurodermatitis, comprises sulfur dispersed in a fat-containing ointment base |